Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2

Carcinogenesis

Volumn 30, Issue 2, 2009, Pages 238-248

  Gordon, Kelly J ^a   Kirkbride, Kellye C ^a   How, Tam ^a   Blobe, Gerard C ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GELATINASE A; OSTEOGENIC PROTEIN 1; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; METASTASIS POTENTIAL; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MESODERM; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; UP-REGULATION;

EID: 60149093710     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn274     Document Type: Article

References (45)

1. Li,D. et al. (2004) Pancreatic cancer. Lancet, 363, 1049-1057.
2. Thiery,J.P. et al. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol., 7, 131-142.
3. Egeblad,M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2 161-174.
4. Ma,L. et al. (2005) Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development, 132, 5601-5611.
5. Deng,H. et al. (2007) Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp. Cell Res., 313, 1033-1044.
6. Rothhammer,T. et al. (2007) Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene, 26 4158-4170.
7. Yang,S. et al. (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res. 65, 5769-5777.
8. Hamada,S. et al. (2007) Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J. Cell. Physiol., 213, 768-774.
9. Miyazono,K. et al. (2005) BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev., 16, 251-263.
10. Theriault,B.L. et al. (2007) BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis, 28 1153-1162.
11. Bardeesy,N. et al. (2006) Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev., 20, 3130-3146.
12. Kleeff,J. et al. (1999) Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology, 116, 1202-1216.
13. Gordon,K.J. et al. (2008) Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis, 29, 252-262.
14. Mazerbourg,S. et al. (2005) Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J. Biol. Chem., 280, 32122-32132.
15. Bau,B. et al. (2002) Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilage. J. Bone Miner. Res., 17, 2141-2150.
16. Xu,G. et al. (2001) Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: Loss of smad3 in choriocarcinoma cells. Biochem. Biophys. Res. Commun., 287, 47-55.
17. Chaudhary,J. et al. (2001) Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology, 142, 1727-1736.
18. Zou,M. et al. (2004) Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: Identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma. J. Clin. Endocrinol. Metab., 89, 6146-6154.
19. Burke,J.M. et al. (1999) Expression of E-cadherin by human retinal pigment epithelium: Delayed expression in vitro. Invest. Ophthalmol. Vis. Sci., 40, 2963-2970.
20. Yokoyama,K. et al. (2001) Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol., 37, 65-71.
21. Givant-Horwitz,V. et al. (2004) Laminin-induced signaling in tumor cells: The role of the M(r) 67,000 laminin receptor. Cancer Res., 64, 3572-3579.
22. Pannu,J. et al. (2007) Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J. Biol. Chem., 282, 10405-10413.
23. Akagi,T. et al. (1977) Establishment and characteristics of a human pancreatic cancer cell line (HCG-25). Acta Pathol. Jpn., 27, 51-58.
24. Rhodes,D.R. et al. (2007) Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 9, 166-180.
25. Hotz,B. et al. (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin. Cancer Res., 13, 4769-4776.
26. Ellenrieder,V. et al. (2001) Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res., 61, 4222-4228.
27. Nakajima,S. et al. (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin. Cancer Res., 10, 4125-4133.
28. Hempel,N. et al. (2008) Expression of the type III TGF-beta receptor negatively regulated by TGF-beta. Carcinogenesis, 29 905-912.
29. Kirkbride,K.C. et al. (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J. Biol. Chem, 283, 7628-7637.
30. Ellenrieder,V. et al. (2001) TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int. J. Cancer, 93 204-211.
31. Hempel,N. et al. (2007) Loss of betaglycan expression in ovarian cancer: Role in motility and invasion. Cancer Res., 67, 5231-5238.
32. Lopez-Casillas,F. et al. (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell, 73, 1435-1444.
33. Southwood,M. et al. (2008) Regulation of bone morphogenetic protein signalling in human pulmonary vascular development. J. Pathol., 214, 85-95.
34. Cannito,S. et al. (2008) Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis, 29, 2267-2278.
35. Jungert,K. et al. (2007) Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res., 67, 1563-1570.
36. Wan,M. et al. (2005) SCF (beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells. Am. J. Pathol., 166, 1379-1392.
37. Fong,S. et al. (2003) Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl Acad. Sci. USA 100, 13543-13548.
38. Bardeesy,N. et al. (2002) Pancreatic cancer biology and genetics. Nat. Rev. Cancer, 2, 897-909.
39. Dong,M. et al. (2007) The type III TGF-beta receptor suppresses breast cancer progression. J. Clin. Invest., 117, 206-217.
40. Turley,R.S. et al. (2007) The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Res., 67, 1090-1098.
41. Finger,E.C. et al. (2008) TbRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Carcinogenesis, 29, 528-535.
42. Langenfeld,E.M. et al. (2006) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene, 25, 685-692.
43. Goulley,J. et al. (2007) BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion. Cell Metab., 5, 207-219.
44. Kim,S.K. et al. (2002) Signaling and transcriptional control of pancreatic organogenesis. Curr. Opin. Genet. Dev., 12, 540-547.
45. Hua,H. et al. (2006) BMP4 regulates pancreatic progenitor cell expansion through Id2. J. Biol. Chem., 281, 13574-13580.